Delivery Order SPE2DB20D2014-SPE2DB25FB85U
- Not listed
- The Defense Logistics Agency awarded a $37,218.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on May 8, 2025, with an ultimate completion date of May 9, 2025. This non-competitive award, issued from the prime contractor's location in Conshohocken, Pennsylvania, represents a single delivery order fulfillment under an existing contract vehicle. Orencia (abatacept) is a biologic immunosuppressant medication used in the treatment of rheumatoid...
- The Defense Logistics Agency awarded a $6,473.76 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location at the same address. Orencia (abatacept)...
- The Defense Logistics Agency awarded a delivery order valued at $25,022.24 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic disease-modifying antirheumatic drug used to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Orencia 125 mg/ml syringes valued at $14,495.04. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The place of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,698.20 for Orencia ClickJect 125 mg/ml on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-competitive, firm fixed-price delivery order represents a small-value pharmaceutical procurement under the company's larger indefinite delivery contract with DLA Troop Support Medical. The performance location is listed as AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $38,328.21 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $3,748.72 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic immunosuppressant medication used primarily in the treatment of...
- The Defense Logistics Agency awarded a $27,538.31 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml on April 21, 2025, with completion scheduled for April 22, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger prime vendor agreement with DLA Troop Support Medical. Orencia (abatacept) is a biologic medication commonly used to treat rheumatoid arthritis and other autoimmune conditions, with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes valued at $8,602.31 on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes valued at $20,773.97 on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FB85UDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for Orencia ClickJect 125 mg/ml with a ceiling value of $9,679.46. This is a firm fixed price delivery order with no set-aside designation, reflecting open competitive procurement. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. Performance will be completed by May 7, 2025, at the contractor's facility in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic immunosuppressant used to treat rheumatoid arthritis and other autoimmune conditions. This delivery order reflects AmerisourceBergen's critical role as a prime pharmaceutical vendor supplying specialized medications to support military and veteran healthcare systems. The contractor's extensive portfolio with DLA demonstrates its established capability to fulfill federal medical supply requirements through competitive procurement across multiple therapeutic domains, including specialty medications, biologics, and medical devices that support Defense Health Agency and broader federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 5/6/25 |